Status:
COMPLETED
Combination Treatment for Moderate to Severe Acne
Lead Sponsor:
Medicis Global Service Corporation
Conditions:
Acne
Eligibility:
All Genders
12-30 years
Phase:
PHASE4
Brief Summary
To determine if a combination of three currently approved acne products are safe and effective for the treatment of moderate to severe acne
Detailed Description
A Phase IV, Open-Label Study Evaluating the treatment for Combination Acne Therapy.
Eligibility Criteria
Inclusion
- moderate to severe acne, IGA = 3 or 4 (Investigator Global Assessment)
Exclusion
- pregnancy and allergies
Key Trial Info
Start Date :
September 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2011
Estimated Enrollment :
97 Patients enrolled
Trial Details
Trial ID
NCT01206348
Start Date
September 1 2010
End Date
July 1 2011
Last Update
November 30 2011
Active Locations (10)
Enter a location and click search to find clinical trials sorted by distance.
1
Birmingham, Alabama, United States
2
Santa Monica, California, United States
3
Hockessin, Delaware, United States
4
Chestnut Hill, Massachusetts, United States